About Crista Galli Ventures
Crista Galli Ventures is a venture capital firm founded in 2019. It is primarily based out of Copenhagen, Denmark. As of Dec 2024, Crista Galli Ventures has invested in 33 companies. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and High Tech. Most recently it participated in the $***** Seed round of EnAcuity Overall, Crista Galli Ventures portfolio has seen 4 acquisitions including key companies like Gleamer, Contextflow and Apryl. A lot of funds co-invest with Crista Galli Ventures, with names like Amadeus Capital sharing a substantial percentage of its portfolio. Crista Galli Ventures has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Portfolio Soonicorns
Crista Galli Ventures' List of Top Investments
Crista Galli Ventures has a portfolio of 33 companies. Their most notable investments are in Adni and Gleamer.Their portfolio spans across United Kingdom, United States, Germany and 5 more locations. They have invested in HealthTech, Enterprise Applications, High Tech and 5 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Crista Galli Ventures:
Subtle Medical is a developer of an AI-driven solution for medical diagnostic imaging. It provides deep learning-based solutions to enhance the quality, efficiency, and diagnostic value for medical imaging by enabling the better acquisition, reconstruction, processing, and analysis of imaging data.
Key facts about Subtle Medical
- Founded Year: 2017
- Location: Palo Alto (United States)
- Stage: Series C
- Total Funding till date: $86M
- Employee Count: 78 as on Jul 31, 2026
- Investors: Samsung Venture Investment, Black River Ventures and 27 Others
- Latest Funding Round: Series C, Jun 02, 2026, $*****
- Highlight: Editors' Pick
Provider of AI-based radiology platform for patient data mining. The browser-based, vendor-neutral system does not require any installation. Radiologists can generate the report directly from a workstation without entering any sensitive patient data.
Key facts about Smart Reporting
- Founded Year: 2014
- Location: Munich (Germany)
- Stage: Series C
- Total Funding till date: $47.4M
- Employee Count: 135 as on May 31, 2026
- Investors: Wessel Management, European Investment Bank and 44 Others
- Latest Funding Round: Series C, Apr 22, 2024, $*****
- Highlight: Editors' Pick
3. Gleamer
Developer of artificial intelligence software for medical imaging diagnostic analysis. This technology integrates with existing radiology workflows to assist in the detection and assessment of pathologies across various modalities including X-ray, computed tomography, and magnetic resonance imaging. The software provides automated measurements, worklist prioritization, and reporting assistance to support clinical image interpretation. These tools function as a gateway for deploying diagnostic algorithms that process medical data to identify abnormalities in bone, chest, breast, and neurological scans.
Key facts about Gleamer
- Founded Year: 2017
- Location: Paris (France)
- Stage: Acquired
- Total Funding till date: $40M
- Employee Count: 125 as on Jul 31, 2026
- Investors: Kima Ventures, Crista Galli Ventures and 11 Others
- Latest Funding Round: Series B, Jun 28, 2023, $*****
- Highlight: Acquired
4. Quibim
Developer of medical imaging software for radiomics and biomarker analysis. This software extracts quantitative features from medical images to support clinical research and diagnostic workflows. The platform manages, indexes, and harmonizes imaging data while integrating with electronic health records. It provides automated tools for analyzing specific organ systems, including the prostate, brain, liver, breast, and lung. These tools facilitate the calculation of volumetric data and the identification of imaging patterns to assist in disease classification and monitoring. The technology functions as a cloud-based system for processing and storing medical imaging data in compliance with data security standards.
Key facts about Quibim
- Founded Year: 2015
- Location: Valencia (Spain)
- Stage: Series A
- Total Funding till date: $60M
- Employee Count: 117 as on Jul 31, 2026
- Investors: Philips HealthWorks, APEX Ventures and 20 Others
- Latest Funding Round: Series A, Jan 28, 2025, $*****
- Highlight: Editors' Pick
5. Contextflow
Developer of software for analyzing medical chest computed tomography scans. This technology assists radiologists by detecting and quantifying lung nodules and identifying patterns associated with pulmonary diseases. The system provides tools for tracking findings over time and supports the diagnostic process by offering qualitative information and differential diagnosis references. The software integrates into existing clinical imaging workflows to facilitate the assessment of lung conditions.
Key facts about Contextflow
- Founded Year: 2016
- Location: Vienna (Austria)
- Stage: Acquired
- Total Funding till date: $8.11M
- Employee Count: 31 as on Jul 31, 2026
- Investors: Philips HealthWorks, APEX Ventures and 11 Others
- Latest Funding Round: Grant (prize money), 2023, $*****
- Highlight: Acquired
Crista Galli Ventures' Year-on-Year Investment Trends
Crista Galli Ventures has invested in 33 companies over the last 6 years, with an average of 2 new investments annually in the last 5 years. Its most recent first time investment was in EnAcuity and most recent follow-on round was in Collective Minds Radiology.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 2 | 0 | 2 |
2023 | 1 | 2 | 3 |
2022 | 7 | 0 | 7 |
2021 | 5 | 1 | 6 |
2020 | 4 | 0 | 4 |
Crista Galli Ventures' Investments by Stage
Crista Galli Ventures has made 12 investments in Seed stage with an average round size of $2.74M and 7 investments in Series A stage with an average round size of $7.59M.Stage of entry | No. of Investments |
|---|---|
Seed | 12 |
Series A | 7 |
Note: We have considered here, only first round of investments
Crista Galli Ventures' Investments by Sector
Crista Galli Ventures has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Vertical SaaS, Life Sciences and Artificial Intelligence - Industry Applications. Notably, it has invested in 32 Tech companies, 23 Enterprise (B2B) companies, 20 Software companies and at least 13 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 16 |
Enterprise Applications | 10 |
Vertical SaaS | 7 |
Life Sciences | 5 |
Artificial Intelligence - Industry Applications | 4 |
Others | 10 |
Note: We have considered here, only first round of investments
Crista Galli Ventures' Investments by Geography
Crista Galli Ventures has made most investments in United Kingdom (10), followed by United States where it has made 4 investments.Country | No. of Investments |
|---|---|
United Kingdom | 10 |
United States | 4 |
Sweden | 2 |
Austria | 1 |
France | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Crista Galli Ventures' recent investments
Crista Galli Ventures has not made any investment in 2026 so far.Here are the most recent investments by Crista Galli Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 20, 2024 | United Kingdom | Seed | 2505 | ||
Feb 29, 2024 | United Kingdom | Series A | 3799 | [+3] | |
Aug 28, 2023 | Sweden | Series B | 9660 | ||
Jun 28, 2023 | France | Series B | 8317 | [+7] | |
Apr 14, 2023 | United Kingdom | Series A | 7762 | [+4] |
Acquired companies in Crista Galli Ventures' Portfolio
4 companies from Crista Galli Ventures' portfolio have been acquired. The most recent acquisition was Contextflow in Jun 2026 by 4DMedical for $*****.Here are Crista Galli Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 01, 2026 | Jun 01, 2021 | Series A | 8273 | |
Mar 02, 2026 | Sep 24, 2020 | Series A | 1432 | |
Jan 23, 2025 | Nov 15, 2022 | Seed | 7472 | |
Jun 24, 2024 | Apr 28, 2022 | Seed | 3455 |
Team profile of Crista Galli Ventures
Crista Galli Ventures has a team of 1 member located in United Kingdom. Crista Galli Ventures' team does not sit on the board of any company as of now.Co-investors of Crista Galli Ventures
Over the past 6 years, 154 investors have co-invested in Crista Galli Ventures's portfolio companies. This includes funds and angels.
- Invested before Crista Galli Ventures: Europa, Y Combinator and 30 others have invested in rounds before Crista Galli Ventures. There are 3 companies where Europa has invested before Crista Galli Ventures and 3 companies where Y Combinator has invested before Crista Galli Ventures.
- Top Co-investors of Crista Galli Ventures: 76 investors entered a company along with Crista Galli Ventures. These include investors like Amadeus Capital (2 companies).
- Invested after Crista Galli Ventures: A total of 46 investors have invested in Crista Galli Ventures's portfolio after their investments. Top Investors include UI Investissement (2 companies), Jonathan Milner (2 companies) and BlueRun Ventures (1 company).
Recent News related to Crista Galli Ventures
•
Vitrue Health wins its next $4M to address UK musculoskeletal issuesTech Funding News•Mar 06, 2024•Vitrue Health, MMC Ventures, Salica Investments, Simplyhealth and 1 other
•
London-based Vitrue Health raises €3.7 million to digitally tackle neck and back pain at workEU-Startups•Feb 29, 2024•Vitrue Health, MMC Ventures, Salica Investments, Simplyhealth and 3 others
•
Gleamer Raises €27 Million in Series B FundingMedical Product Outsourcing•Sep 05, 2023•Gleamer, Supernova Invest, Heal Capital, XAnge and 7 others
•
•
•
Gleamer Raises €27 Million In Series B Funding RoundMedical Device News•Jun 28, 2023•Gleamer, UI Investissement, Crista Galli Ventures, MACSF and 10 others
•
Pear Bio Secures $14 Million Series A Funding to Advance Predictive Cancer TreatmentSilicon Valley Journals•May 17, 2023•Pear Bio, Octopus Ventures, Hoxton Ventures, Crista Galli Ventures and 2 others
•
Surgery Hero Raises £2.5M in Seed FundingFinSMEs•Nov 15, 2022•Surgery Hero, LifeArc, Crista Galli Ventures, Clarendon Fund Managers and 4 others
•
Cambridge's CardiaTec Secures £1.4m to combat cardiovascular diseases using AIBdaily•Jul 06, 2022•CardiaTec, Laidlaw Scholars Ventures, APEX Ventures, Crista Galli Ventures and 2 others
•
Anja Health Raises $4.5M in Seed FundingFinSMEs•May 09, 2022•Anja, Seven Seven Six, Harvest Venture Partners, Crista Galli Ventures
